tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 221 are a BUY (87.35%), 31 are a HOLD (12.25%), 1 are a SELL (0.4%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 39.99% that have a potential upside of 56.34% achieved within 165 days.
Robert Driscoll’s has documented 509 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KURA, Kura Oncology at 14-Nov-2025.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
$0.59 (13.38%)
$5
1 months ago
(14-Nov-2025)
4/14 (28.57%)
$0.44 (9.65%)
136
Buy
$5
$0.59 (13.38%)
$5
10 months 23 days ago
(21-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
$5
$0.59 (13.38%)
$4
1 years 4 months 12 days ago
(02-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$5
$0.59 (13.38%)
3 years 10 months 12 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
4 years 5 months 16 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
